XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of revenue
The following table represents Evolent’s revenue disaggregated by segment and end-market for the years ended December 31, 2021, 2020 and 2019 (in thousands):
For the Year Ended December 31,
202120202019202120202019
Evolent Health ServicesClinical Solutions
Medicaid$215,236 $236,634 267,222 $205,833 $274,028 75,675 
Medicare26,358 68,505 73,671 363,053 257,092 199,817 
Commercial and other68,219 77,221 68,012 29,258 11,159 2,725 
Total$309,813 $382,360 408,905 $598,144 $542,279 278,217 
Contract with customer, asset and liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of December 31, 2021 and 2020 (in thousands):
December 31,
2021
2020 (1)
Short-term receivables (2)
$129,012 $118,730 
Long-term receivables (2)
4,877 4,554 
Short-term contract assets— 329 
Short-term deferred revenue11,944 10,187 
Long-term deferred revenue4,437 3,593 
————————
(1)Amounts exclude $3.4 million of short-term receivables and $4.1 million of short-term deferred revenue reclassified to discontinued operations as of December 31, 2020.
(2)Excludes pharmacy claims receivable and premiums receivable.
Changes in deferred revenue for the year ended December 31, 2021 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$13,780 
Reclassification to revenue, as a result of performance obligations satisfied(10,175)
Cash received in advance of satisfaction of performance obligations12,776 
Balance as of end of period$16,381